Asian Spectator

The Times Real Estate

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Pembabatan hutan picu penyakit: Pemerintah jangan abai

Prabowo-Gibran yang pencalonannya sebagai Presiden dan Wakil Presiden memantik kontroversi telah mulai bekerja sejak 20 Oktober 2024.Untuk mengawal pemerintahan mereka, kami menerbitkan edisi khusus #...

Cemas berat badan naik saat libur Natal Tahun Baru? Siasati dengan 4 cara ini

Fractal Pictures/ ShutterstockMakan bersama saat musim liburan, seperti Natal dan Tahun Baru bisa menjadi momen yang menyenangkan. Namun, bagi kamu yang mengalami kecemasan terhadap makanan karena mas...

Pilkada 2024: Kemenangan rakyat atau Jokowi-Prabowo?

Presiden Prabowo Subianto (kiri), mantan Presiden Joko Widodo (tengah) dan Wakil Presiden Gibran Rakabuming Raka menghadiri Peringatan 79 tahun TNI.Donny Hery/ShutterstockPilkada Serentak 2024 menjadi...